Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Overweight 1Obesity 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Exenatide × Clear all
NCT04969627 2022-04-14

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

Shengjing Hospital

Phase 4 Completed
60 enrolled

Polycystic Ovary Syndrome

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

RenJi Hospital

Phase 4 Completed
183 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT04029272 2019-07-23

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Peking Union Medical College Hospital

Phase 4 Unknown
80 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡